These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37241901)

  • 1. Nature of Luminescence and Pharmacological Activity of Sulfaguanidine.
    Tchaikovskaya O; Bocharnikova E; Bazyl O; Chaidonova V; Mayer G; Avramov P
    Molecules; 2023 May; 28(10):. PubMed ID: 37241901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfadimethoxine and sulfaguanidine: their sorption potential on natural soils.
    Białk-Bielińska A; Maszkowska J; Mrozik W; Bielawska A; Kołodziejska M; Palavinskas R; Stepnowski P; Kumirska J
    Chemosphere; 2012 Mar; 86(10):1059-65. PubMed ID: 22197018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical stability of sulfaguanidine suspensions.
    Jones RD; Matthews BA; Rhodes CT
    J Pharm Sci; 1970 Apr; 59(4):518-20. PubMed ID: 5440679
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of polybasic antibiotics and sulfaguanidine on absorption and excretion of cholesterol and bile salts.
    Eyssen H; Vanderhaeghe H; De Somer P
    Fed Proc; 1971; 30(6):1803-7. PubMed ID: 5124964
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation, characterization and biological activity of Fe(III), Fe(II), Co(II), Ni(II), Cu(II), Zn(II), Cd(II) and UO(2)(II) complexes of new cyclodiphosph(V)azane of sulfaguanidine.
    Sharaby CM
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Nov; 62(1-3):326-34. PubMed ID: 16257733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of cholesterol absorption by sulfaguanidine.
    Eyssen HJ; Van den Bosch JF; Janssen GA; Vanderhaeghe H
    Atherosclerosis; 1971; 14(2):181-92. PubMed ID: 5118612
    [No Abstract]   [Full Text] [Related]  

  • 7. The Effect of Several Compounds on the Inhibition of Bacterial Growth by Sulfaguanidine, Sulfamerazine, and Sulfasuxidine.
    Clapper WE; Kurita IT
    J Bacteriol; 1948 Feb; 55(2):277-84. PubMed ID: 16561456
    [No Abstract]   [Full Text] [Related]  

  • 8. Agranulocytosis induced by sulfaguanidine. The danger of an antibacterial drug in a symptomatic remedy.
    Stevens AR
    Arch Intern Med; 1969 Apr; 123(4):428-9. PubMed ID: 5778122
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific inhibition of cholesterol absorption in sulfaguanidine-fed rats.
    Van den Bosch JF; Janssen GA; Eyssen H; Vanderhaeghe H
    J Nutr; 1971 Nov; 101(11):1515-23. PubMed ID: 5124039
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on synthetic sweetening agents. XVII. Metabolism of sodium cyclamate. (6). Influences of neomycin and sulfaguanidine on metabolism of sodium cyclamate.
    Suenaga A; Kojima S; Ichibagase H
    Chem Pharm Bull (Tokyo); 1972 Jul; 20(7):1357-61. PubMed ID: 4640445
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of sulfaguanidine on the biogenesis of ascorbic acid in the rat.
    Rao MV; Chandrasekhara N; Srinivasan M
    Proc Soc Exp Biol Med; 1968 Jun; 128(2):402-7. PubMed ID: 5663245
    [No Abstract]   [Full Text] [Related]  

  • 12. THE NATURE AND CONTROL OF REACTIONS IN BIOLUMINESCENCE : WITH SPECIAL REFERENCE TO THE MECHANISM OF REVERSIBLE AND IRREVERSIBLE INHIBITIONS BY HYDROGEN AND HYDROXYL IONS, TEMPERATURE, PRESSURE, ALCOHOL, URETHANE, AND SULFANILAMIDE IN BACTERIA.
    Johnson FH; Eyring H; Steblay R; Chaplin H; Huber C; Gherardi G
    J Gen Physiol; 1945 May; 28(5):463-537. PubMed ID: 19873433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfaguanidine protection of mouse liver from carbon tetrachloride-induced necrosis.
    Leduc LH
    Lab Invest; 1973 Aug; 29(2):186-96. PubMed ID: 4353417
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of bile salts on the gastrointestinal absorption of drugs. II. Mechanism of the enhancement of the intestinal absorption of sulfaguanidine by bile salts.
    Kakemi K; Sezaki H; Konishi R; Kimura T; Okita A
    Chem Pharm Bull (Tokyo); 1970 May; 18(5):1034-9. PubMed ID: 5419238
    [No Abstract]   [Full Text] [Related]  

  • 15. The absorption of some sulphaguanidine derivatives in mice.
    Rose FL; Spinks A
    Br J Pharmacol Chemother; 1947 Jun; 2(2):65-78. PubMed ID: 19108113
    [No Abstract]   [Full Text] [Related]  

  • 16. EFFECTS OF SULFAGUANIDINE ON RAT SUBMAXILLARY GLAND.
    BERARD CW; WOODWARD SC
    Proc Soc Exp Biol Med; 1964 Mar; 115():777-81. PubMed ID: 14155827
    [No Abstract]   [Full Text] [Related]  

  • 17. [PHYSICO-CHEMICAL AND AUTOMATIC METHODS OF TECHNOLOGIC CONTROL IN THE PRODUCTION OF PHARMACOLOGICAL PREPARATIONS. V. STUDY ON THE SOLUBILITY OF SULFANILAMIDE, SULGIN AND SULFADIMEZIN AT VARIOUS PH AND TEMPERATURE OF SOLUTIONS].
    PORTNOV MA; ZASOSOV VA; VESELITSKAIA TA; MIKHALEV VA
    Med Prom SSSR; 1964 Feb; 18():36-9. PubMed ID: 14187532
    [No Abstract]   [Full Text] [Related]  

  • 18. [Types of dysenterial bacilli observed during 1956-1959. Sensitivity of cultivated strains to sulfaguanidine and antibiotics and comparison of results observed in vitro with therapeutic results].
    ANUSZ Z; GRABINSKI A; NAREBSKI J
    Przegl Epidemiol; 1960; 14():267-72. PubMed ID: 14448354
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental alterations of the ergastoplasm of the mouse liver.
    Wilson JW; Leduc EH
    Rev Int Hepatol; 1967; 17(8):883-93. PubMed ID: 5600369
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition by sulfonamides of the biosynthesis of folic acid.
    Brown GM
    Int J Lepr Other Mycobact Dis; 1967; 35(4):580-9. PubMed ID: 4869692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.